基于FIGO 2018分期的动态增强MRI在宫颈癌术前分期中的诊断价值

doi:10.3969/j.issn.1671-7171.2025.01.029

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1446 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the diagnostic value of dynamic enhanced magnetic resonance imaging (MRI) in the preoperative staging of cervical cancer based on the staging of International Federation of Obstetrics and Gynecology (FIGO) 2018. 【Methods】Clinical data of 78 patients with cervical cancer admitted to our hospital from January 2021 to August 2022 were retrospectively analyzed, all of which were confirmed by surgical pathological examination. All patients underwent dynamic enhanced magnetic MRI before surgery. Based on FIGO 2018 staging, the consistency of preoperative staging diagnosis with pathological diagnosis was compared. The diagnostic value of dynamic enhanced magnetic MRI in preoperative staging of cervical cancer was analyzed. 【Results】Pathological examination showed that the pathological types of 78 cervical cancer patients were adenocarcinoma in 7 cases, squamous cell carcinoma in 67 cases, adenosquamous cell carcinoma in 2 cases, poorly differentiated cervical neuroendocrine carcinoma in 1 case and small cell carcinoma in 1 case. Kappa consistency test analysis showed that dynamic enhanced MRI based on FIGO 2018 staging was in good agreement with pathological diagnosis of cervical cancer in preoperative staging (Kappa=0.766, P<0.05). The accuracy of dynamic enhanced MRI based on FIGO 2018 staging in the diagnosis of preoperative stage ⅠB1, ⅠB2, ⅠB3, ⅡA1, ⅡA2 and ⅢC1 was 97.44%, 89.74%, 93.59%, 92.31%, 94.87% and 94.87%, respectively. 【Conclusion】The diagnosis of cervical cancer by dynamic enhanced MRI based on FIGO 2018 staging has good consistency with pathological diagnosis and high diagnostic accuracy.

Key words： Uterine Cervical Neoplasms Magnetic Resonance Imaging Neoplasm Staging Diagnosis

Received: 28 September 2023

PACS:

R711.74

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FU Yuying

Cite this article:

FU Yuying. Value of Dynamic Enhanced MRI Based on FIGO 2018 Staging in Preoperative Staging Diagnosis of Cervical Cancer[J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(1): 102-104.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2025.01.029 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2025/V42/I1/102

[1] 邱海波,曹素梅,徐瑞华.基于2020年全球流行病学数据分析中国癌症发病率、死亡率和负担的时间趋势及与美国和英国数据的比较[J].癌症,2022,41(4):165-177.
[2] 曹玉叶,黎志强,郝敏,等.FIGO 2018子宫颈癌新分期ⅠB期各亚分期设置的合理性探讨[J].中国实用妇科与产科杂志,2021,37(4):468-473.
[3] 李昌玉,李建. 高分辨率MRI联合MSCT及经阴超声检查对宫颈癌患者术前分期的诊断价值[J].医学影像学杂志,2020,30(5):803-805.
[4] 薛利,黄伟.多普勒超声、MSCT及MRI在诊断宫颈癌中的应用比较[J].中国CT和MRI杂志,2020,18(1):114-117.
[5] 黎志强,刘佳琪.FIGO 2018子宫颈癌中ⅡA期分期合理性探讨[J].中国实用妇科与产科杂志,2021,37(5):577-581.
[6] 周琦,吴小华,刘继红,等.宫颈癌诊断与治疗指南(第四版)[J].中国实用妇科与产科杂志,2018,34(6):613-622.
[7] 鲁琦, 张震宇. 国际妇产科联盟2018年版子宫颈癌分期标准的解读[J].中华妇产科杂志, 2019, 54(10):718-720.
[8] 李建伟, 秦邦辉, 孙雷,等. 苏北地区农村女性宫颈癌筛查知识,意愿及行为的调查与分析[J].中国性科学, 2021, 30(10):30-33.
[9] 孙璐,丁文,张宏彬.早中期宫颈癌患者MRI与常规CT影像学特点及对手术治疗的指导价值[J].中国妇幼保健,2020,35(14):2720-2722.
[10] 王静,曾小松.弥散加权成像联合磁共振动态增强扫描在宫颈癌术前分期中诊断价值研究[J].临床军医杂志,2021,49(6):713-717.
[11] 许华宇,王春凯.应用MSCT、MRI检查对浸润性宫颈癌术前分期的临床诊断价值对比研究[J].中国CT和MRI杂志,2021,19(12):127-129.
[12] 郭强蕊,张士奇,毛泽宇,等.MRI与MSCT检查对浸润性宫颈癌术前分期的临床价值[J].医学影像学杂志,2022,32(6):1069-1072.
[13] 胡毓婷,鹿秀霞,练为芳,等.超声造影定量与动态增强MRI定量在宫颈癌诊断中的应用价值[J].现代生物医学进展,2020,20(23):4547-4551.
[14] 张添辉,龙曦,陈思萍,等.基于FIGO 2018分期的宫颈癌MRI术前分期与术后病理分期对照研究[J].实用放射学杂志,2022,38(2):278-281.
[15] 张娜,邹冬玲,郭明芳,等.2018版FIGO分期ⅠA2~ⅡA1期宫颈癌患者的治疗选择和预后分析[J].重庆医科大学学报,2021,46(6):685-690.
[16] 李林,文保钢,赵秀娟,等.FIGO 2018分期系统对子宫颈神经内分泌癌治疗及预后的影响[J].中国肿瘤临床,2020,47(12):621-625.
[17] 张其林,金斌,王华林.DWI-MRI联合血清SCC-Ag、CEA诊断宫颈癌的价值研究[J].中国煤炭工业医学杂志,2020(4):365-368.
[18] 刘益,刘青,刘开江,等.影像学检查在宫颈癌盆腹腔淋巴结转移诊断中的价值[J].国际妇产科学杂志,2022,49(3):296-301.
[19] 秦凤英,马锦涛,赵明丽,等.多参数MRI联合临床分期预测ⅢCr期宫颈癌同步放化疗后复发[J].放射学实践,2021,36(6):767-772.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2025, 42(1): 138-140.